Home Blog Page 1131

Gene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidence at the 2nd International Hereditary Cancers Congress 2026

In Partnership with ATC Genomics, the Company Presented One of Asia’s Largest Real-World Datasets (n=12,281) for AI-Powered Multi-Cancer Early Detection (MCED) and Showcased its Clinically Validated ctDNA-Powered Oncology Portfolio Across the Full Cancer Continuum for High-Risk and Hereditary Populations.

ANTALYA, Türkiye, March 4, 2026 /PRNewswire/ — Gene Solutions announced its strategic entry into the Turkish market at the 2nd International Hereditary Cancers Congress (IHCC), held 05–08 February 2026 in Antalya.

Organized by the Hereditary Cancer Association, IHCC convened medical oncologists, surgical oncologists, clinical geneticists, and laboratory directors to advance evidence-based approaches in hereditary cancer prevention and precision oncology. The 2026 congress brought together over 600 oncology and genetics experts to advance evidence-based hereditary cancer care.

As hereditary cancer care evolves from risk assessment toward earlier detection, personalized surveillance, and preventive precision care, IHCC served as a key platform to discuss the clinical integration of genomic medicine and multidisciplinary models of care.

In collaboration with ATC Genomics Sağlık Teknolojileri A.Ş. (ATC Genomics), a leading Türkiye-based provider and distributor with over 30 years of experience in molecular diagnostics and life sciences—Gene Solutions presented compelling new Real-World Evidence (RWE) from one of the largest Asian cohorts evaluating its MCED assay.(1) Alongside this data, the company showcased its full ctDNA-powered oncology portfolio:

  • SPOT-MAS™: AI-powered Multi-Cancer Early Detection.
  • K-4CARE™: Comprehensive Genomic and Transcriptomic Profiling (CGTP) with longitudinal MRD monitoring.

These multi-omics solutions meet the highest international performance standards, while providing accessible and scalable precision oncology for hereditary and high-risk cohorts across diverse populations.

Industry Satellite Symposium: From Screening to Precision Care
In alignment with this direction, Gene Solutions and ATC Genomics hosted an Industry Satellite Symposium entitled: “From Screening to Precision Care: The ctDNA Continuum in Oncology – Insights for High-Risk and Hereditary Populations.”

From left to right: Prof. Dr. Taha Bahşi, Medical Geneticist and Head of the Genetic Diseases Evaluation Center at Memorial Health Group, Türkiye; Prof. Dr. Mustafa Özdoğan, Medical Oncologist and Head of the Cancer Center at Memorial Health Group, Türkiye; Dr. Le Son Tran, Principal Investigator at Gene Solutions; Dr. Terence Aik Huang Tan, Medical Oncologist at International Cancer Specialists, Singapore and Dr. Duy Sinh Nguyen, Oncology Medical Director at Gene Solutions.
From left to right: Prof. Dr. Taha Bahşi, Medical Geneticist and Head of the Genetic Diseases Evaluation Center at Memorial Health Group, Türkiye; Prof. Dr. Mustafa Özdoğan, Medical Oncologist and Head of the Cancer Center at Memorial Health Group, Türkiye; Dr. Le Son Tran, Principal Investigator at Gene Solutions; Dr. Terence Aik Huang Tan, Medical Oncologist at International Cancer Specialists, Singapore and Dr. Duy Sinh Nguyen, Oncology Medical Director at Gene Solutions.

Co-chaired by Prof. Dr. Mustafa Özdoğan, Medical Oncologist and Head of the Cancer Center at Memorial Health Group, Türkiye and Prof. Dr. Taha Bahşi, Medical Geneticist and Head of the Genetic Diseases Evaluation Center at Memorial Health Group, Türkiye, the program addressed the full ctDNA continuum—delivering actionable evidence from early cancer screening to therapy guidance and longitudinal surveillance—with a focus on hereditary and high-risk populations.

  • Dr. Le Son Tran, Principal Investigator at Gene Solutions, presented “SPOT-MAS: A Multi-Omics Approach to Cancer Detection”.
    He addressed limitations of single-organ screening and highlighted SPOT-MAS technology, including cfDNA multi-omics integration, machine learning, which integrates genetic, epigenetic, and fragmentomic signatures from a single blood draw to detect 10 cancer types and 75 subtypes. In addition, he showcased the K-DETEK prospective study (9,024 asymptomatic individuals), demonstrating 78.1% sensitivity and 99.8% specificity, with AI-driven tissue-of-origin accuracy of 84%, underscoring affordability and scalability for population-level impact in high-risk cohorts.
  • Dr. Duy Sinh Nguyen, Oncology Medical Director at Gene Solutions, presented “Beyond DNA: Integrated Comprehensive Genomic & Transcriptomic Profiling with Longitudinal MRD Monitoring”. 
    He introduced the K-4CARE platform, a unified workflow that integrates genomic and transcriptomic profiling for fusion detection, immune signatures, and therapy selection while also providing personalized ctDNA-MRD status for precise surveillance. The talk covered methodology, analytical/clinical performance, real-world cases, and practical implementation pathways to advance precision treatment.
  • Dr. Terence Aik Huang Tan, Medical Oncologist at International Cancer Specialists, Singapore, presented “Current Clinical Practice and Future Directions of ctDNA-MRD Monitoring”. 
    Offering an independent perspective, he reviewed the current international guideline landscape (including NCCN, ESMO, and JSCO), real-world scenarios from Asia, and highlighted clinical spaces of equipoise in the NCCN guidelines—where ctDNA-MRD can support shared decision-making and guide escalation or de-escalation, with potential to significantly extend median overall survival.

The session concluded with an interactive Q&A moderated by Prof. Dr. Mustafa Özdoğan and Prof. Dr. Taha Bahşi.

Oral Presentation Highlight at IHCC: Large-Scale Real-World Evidence for Multi-Cancer Early Detection in Asia
Dr. Luu Hong Dang Nguyen, Deputy Medical Director at Gene Solutions, presented results from one of the largest RWE datasets in Asia evaluating SPOT-MAS. In a real-world cohort of 12,281 individuals (median age 43 years) enriched for familial cancer risk and followed for 12 months, SPOT-MAS demonstrated sensitivity of 78.2%, specificity of 99.8%, PPV of 67%, NPV of 99.9%, and tumor-of-origin accuracy of 82.0%, consistent with K-DETEK prospective validation.

Dr. Dang Nguyen emphasized the shift toward “cancer interception”—proactive detection and treatment of precancerous lesions to reduce future cancer burden and outlined Gene Solutions’ focus on high-risk genetic and familial cohorts.

Read details on symposium insights and oral presentation: https://genesolutions.com/news/gene-solutions-atc-introducing-oncology-portfolio-in-turkey-at-the-2nd-international-hereditary-cancers-congress-with-industry-symposium-oral-presentation/

Strong Momentum from Turkish Clinicians
“Türkiye serves as a strategic gateway for precision oncology across Europe, Central Asia, the Middle East and Africa. Together with ATC Genomics, we are bringing clinicians accessible, clinically validated ctDNA solutions—from early detection to treatment decision-making and surveillance—that meet the highest international performance standards and are backed by robust RWE,” said Dr. Özgüncem Bozkulak, General Manager, TR-EEMEA-CIS, Gene Solutions. “Our multi-omics platforms and growing clinical evidence base reflect our commitment to improving outcomes for patients with hereditary and high-risk cancer while supporting localized, scalable implementation.”

“We are proud to partner with Gene Solutions to expand access to state-of-the-art liquid biopsy technologies in Türkiye,” said Burcu Torun, Managing Partner and General Manager, ATC Genomics. “This collaboration strengthens our portfolio and supports the Turkish oncology community with end-to-end solutions that can be integrated into daily clinical practice.”

Gene Solutions thanks the Hereditary Cancer Association, congress leadership, speakers, and participants for an impactful scientific exchange and looks forward to contributing to the advancement of precision oncology in Türkiye.

(1) Nguyen, L. H. D., et al. (2025). Prospective validation study: a non-invasive circulating tumor DNA-based assay for simultaneous early detection of multiple cancers in asymptomatic adults. BMC Medicine, 23(1).

About Gene Solutions
Gene Solutions is a global biotechnology company headquartered in Singapore with a mission to make advanced genomic solutions accessible and affordable. Leveraging multi-omics, Next-Generation Sequencing (NGS), and Artificial Intelligence, the company offers a comprehensive portfolio, including next-generation prenatal screening for fetal and maternal health (triSure), multi-cancer early detection (SPOT-MAS), and comprehensive tumor profiling and ctDNA monitoring (K-TRACK, K-4CARE).

Since 2017, Gene Solutions has performed over three million genetic tests worldwide through CAP-accredited laboratories across multiple markets. Through continuous innovation and strategic collaborations, the company is advancing earlier cancer detection, precision care, and reproductive health globally.
Learn more: www.genesolutions.com

About ATC Genomics Türkiye
ATC Genomics Sağlık Teknolojileri A.Ş. (ATC Genomics) is a Türkiye-based provider and distributor in molecular diagnostics and life sciences. Since 1996, ATC has brought advanced genomic technologies, high-quality products, and services to clinicians, scientists, and laboratories—supporting disease prevention, early diagnosis, and personalized treatment decisions through international collaborations and innovation. The company emphasizes human-centred values and quality, serving molecular diagnostic and research laboratories in line with international standards, and highlights its “Trusted Partner in Genomics” ethos on its corporate site.
Learn more: www.atc.com.tr

Media Contact
Gene Solutions
Email: pr@genesolutions.com
ATC Genomics
Email: bilgi@atc.com.tr

Advancing Influenza Vaccine Development: Sino Biological Launches Antigens for the 2026-2027 Northern Hemisphere Influenza Vaccine Strains

HOUSTON, March 4, 2026 /PRNewswire/ — The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition, highlighting the continued spread of A(H3N2) subclade K and emerging B/Victoria lineage strains. In rapid response, Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant technology, has launched the 2026-2027 Northern Hemisphere influenza vaccine strain antigens to accelerate vaccine development.

Decoding the 2026-2027 Northern Hemisphere Influenza Vaccine Strains

Since its identification in August 2025, H3N2 subclade K (J.2.4.1) has become the dominant influenza A strain globally. Defined by the T135K and S144N mutations, this strain exhibits enhanced immune escape, prompting WHO to select A/Darwin/1454/2025 as the new H3N2 reference virus. The H1N1 component has been updated to A/Missouri/11/2025. Meanwhile, B/Victoria lineage activity is rising sharply, with proportions increasing from 6% to over 20% in regions including Hong Kong SAR and the U.S., leading WHO to recommend B/Tokyo/EIS13-175/2025 and B/Pennsylvania/14/2025 strains.

Sino Biological’s Comprehensive Reagents for Influenza Research

To support global influenza vaccine research and development, Sino Biological has launched an extensive portfolio of recombinant antigens for the 2026-2027 influenza vaccine strains, including A/Missouri/11/2025 (H1N1) HA Trimer (purity ≥90% verified by SEC-MALS), NA, and NP proteins. “Our mission is to provide the scientific community with the highest quality tools as rapidly as possible when infectious disease evolution threatens global health preparedness,” said Dr. Rob Burgess, Chief Business Officer at Sino Biological US.

About Sino Biological

Sino Biological is a global biotechnology company specializing in high-quality recombinant proteins, antibodies, and customized research services. Serving researchers in more than 90 countries, Sino Biological supports basic research, drug discovery, vaccine development, and diagnostics through its comprehensive product portfolio, proprietary quality systems, and innovative research platforms.

Forward-Looking Statements

Certain statements in this document are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act. These statements are based on Sino Biological management’s current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, over which Sino Biological has no control. Sino Biological assumes no obligation to update these forward-looking statements and does not intend to do so.

For media inquiries or partnership opportunities, please contact:

Sino Biological, Inc.
gmo@sinobiological.cn
www.sinobiological.com

PROTECTHEALTH STRENGTHENS GOVERNANCE AND SERVICE CONTINUITY WITH ISO 22301 BCMS CERTIFICATION

CYBERJAYA, Malaysia, March 4, 2026 /PRNewswire/ — ProtectHealth Corporation Sdn. Bhd. has reinforced its role as a key government agency and strategic purchaser of healthcare services with the successful attainment of the ISO 22301:2019/AMD1:2024 Business Continuity Management System (BCMS) Certification.

ProtectHealth Corporation Sdn. Bhd. Chief Executive Officer, Wan Mohd Hazwan Wan Mohd Najib (right) receiving the ISO 22301 Business Continuity Management System (BCMS) Certification from CyberSecurity Malaysia Acting Chief Executive Officer, Roshdi Hj Ahmad (left), underscoring ProtectHealth’s commitment to strengthening business continuity and organisational resilience.
ProtectHealth Corporation Sdn. Bhd. Chief Executive Officer, Wan Mohd Hazwan Wan Mohd Najib (right) receiving the ISO 22301 Business Continuity Management System (BCMS) Certification from CyberSecurity Malaysia Acting Chief Executive Officer, Roshdi Hj Ahmad (left), underscoring ProtectHealth’s commitment to strengthening business continuity and organisational resilience.

The certification reflects ProtectHealth’s commitment to strong governance and operational resilience, ensuring the continuity of critical healthcare financing initiatives and public-private partnerships. It underscores the organisation’s responsibility to deliver reliable, accessible and uninterrupted healthcare services to beneficiaries nationwide.

The certified BCMS supports the sustained delivery of ProtectHealth managed initiatives, including PeKa B40, Skim Perubatan MADANI, Skim Perlindungan Insurans Kesihatan Pekerja Asing (SPIKPA) and the Hospital Services Outsourcing Programme (HSOP), by safeguarding core operational, financial and coordination functions.

ProtectHealth Corporation’s Chief Executive Officer, Wan Mohd Hazwan Wan Mohd Najib, said the certification demonstrates the organisation’s preparedness in managing disruptions while maintaining service continuity.

“This certification demonstrates our commitment to stakeholders by ensuring that robust systems are in place to protect operations, manage risks effectively and enable swift recovery, so that essential services continue without disruption,” he said.

CyberSecurity Malaysia’s Acting Chief Executive Officer, Roshdi Hj Ahmad, said the achievement reflects ProtectHealth’s proactive approach in embedding business continuity as a core organisational capability.

“Business continuity is a key element of good governance. This certification reflects ProtectHealth’s strong leadership in safeguarding the continuous delivery of critical healthcare services, protecting public resources and strengthening institutional resilience,” he said.

The BCMS certification journey commenced on 17 April 2025, with ProtectHealth successfully fulfilling all certification requirements in less than one year, positioning the organisation among entities that have achieved certification within a notably efficient timeframe.

In line with its continuous improvement agenda, ProtectHealth is also preparing to pursue ISO/IEC 27001 Information Security Management System (ISMS) certification, further strengthening information security governance in alignment with internationally recognised standards.

PROTECTHEALTH CORPORATION SDN. BHD.

About ProtectHealth Corporation Sdn. Bhd.

ProtectHealth Corporation Sdn. Bhd. (ProtectHealth), incorporated on 19 December 2016, is a wholly owned subsidiary of ProtectHealth Malaysia, established under the Ministry of Health Malaysia (MOH). As a not-for-profit company, ProtectHealth is mandated to coordinate, administer, and manage healthcare-related initiatives focusing on sustainable health financing and equitable access to care.

ProtectHealth serves as the scheme administrator for the Skim Perubatan MADANI, Skim Peduli Kesihatan untuk Kumpulan B40 (PeKa B40), and the Hospital Services Outsourcing Programme (HSOP). The company also acts as the electronic service provider (ESP) for the Skim Perlindungan Insurans Kesihatan Pekerja Asing (SPIKPA) and was the key implementer for private medical practitioner and healthcare NGO participation in the National COVID-19 Immunisation Programme (PICK).

Arduino and Qualcomm Launch Hackster’s First Developer Contest of 2026 Global Competition Kicks Off With 300 Arduino UNO Q Boards and Opportunities to Showcase Edge AI Innovation

SAN DIEGO, March 3, 2026 /PRNewswire/ — Arduino and Qualcomm Technologies, Inc. have announced the launch of Hackster’s first global developer contest of 2026, inviting engineers, makers, and innovators worldwide to build groundbreaking projects using the newly introduced Arduino® UNO™ Q platform.

The competition is hosted on Hackster.io and is supported by a strong ecosystem of technology partners, with the goal of accelerating innovation in AI, IoT, robotics, and edge computing. The contest empowers developers to turn bold ideas into real-world solutions that demonstrate the future of connected intelligence.

To support participation, the organizers will give away 300 Arduino UNO Q boards, enabling developers to prototype, experiment, and deploy their ideas on cutting-edge hardware.

At the heart of the competition is the Arduino UNO Q, a hybrid platform that combines a Qualcomm Dragonwing™ QRB2210 MPU running Linux with an STM32 microcontroller for real-time control. This dual-architecture design enables developers to build sophisticated applications that blend AI inference, real-time processing, and cloud connectivity.

Participants will develop using Arduino® App Lab, which allows seamless integration of Arduino sketches, Python applications, and AI models within a single workflow. Native support for machine learning at the edge—including computer vision and audio AI—makes the UNO Q especially well-suited for on-device intelligence.

The board also offers rich connectivity and expandability, including Wi-Fi 5, Bluetooth® 5.1, HDMI, USB-C, camera and display connectors, classic Arduino headers, and Qwiic support, enabling rapid prototyping across a wide range of use cases.

The contest is open to developers of all experience levels, from students and hobbyists to professional engineers. Participants are encouraged to submit projects addressing real-world challenges across multiple domains, including industrial IoT, home automation, robotics, gaming, and social impact.

Projects will be evaluated on innovation, technical execution, user experience, sustainability, and scalability, encouraging participants to think beyond prototypes and toward deployable solutions.

How to Participate

Developers can join the contest by registering on Hackster.io. Winning teams and individuals will receive cash prizes, global visibility on Hackster.io, and industry recognition. The Best in Show award includes a paid trip to Maker Faire Rome 2026, where winners will showcase their projects to an international audience of makers, engineers, and technology leaders.

For more information, please refer to our official press release here.

Cardumen Capital Strengthens Global Reach Through Its Taipei-Based APAC Partner Following NVIDIA’s Acquisition of Its Portfolio Company Illumex

Building on the acquisition of Illumex by NVIDIA, the firm validates its Seed-to-Exit thesis and reinforces its mission to bridge Asian capital with world-class DeepTech.


TAIPEI, TAIWAN – Media OutReach Newswire – 4 March 2026 – Cardumen Capital, a leading European DeepTech venture capital firm, today marks a pivotal milestone in its international momentum following the acquisition of its portfolio company, Illumex, by NVIDIA. This landmark exit further solidifies the firm’s strategic presence in the Asia-Pacific region and cements its 2019 vintage fund’s position as a leading performer within its vintage cohort.

A Seed-to-Exit Success Story

Cardumen Capital was Illumex’s first investor and led its 2021 seed round, supporting the company from inception through to exit. General Partners Gonzalo Martínez de Azagra and Igor de la Sota identified the startup’s potential at the seed stage, guiding it toward this landmark milestone.

“This acquisition validates our DeepTech thesis,” said Gonzalo Martínez de Azagra. “By backing visionary founders early, we demonstrate our ability to identify the core building blocks of the AI era.”

Igor de la Sota added: “The success of the Illumex exit underscores the global demand for robust data infrastructure in the age of Generative AI. We are proud to have supported the team from day one in building a platform that now sits at the heart of the world’s AI computing network.”

Strengthening the Bridge to Asia-Pacific

Illumex joining NVIDIA serves as a powerful catalyst for Cardumen Capital’s mission in Asia. Led by Taipei-based APAC Venture Partner Stan Yu, a serial entrepreneur turned venture capitalist, the firm is intensifying its efforts to bridge Asian strategic capital with world-class innovation hubs in Europe, Israel, and global DeepTech ecosystems.

“Building on this milestone exit to NVIDIA, we are seeing unprecedented momentum for our strategy in the APAC region,” said Stan Yu. “The journey of Illumex proves the caliber of opportunities we bring to our partners. From our base in Asia, we are uniquely positioned to facilitate these high-stakes connections, ensuring that Asian institutional capital has exclusive access to the next wave of transformative DeepTech and frontier innovations.”

As a pioneering venture capital firm with a dedicated partner presence in Taipei bridging the EMEA tech ecosystem, Cardumen Capital is uniquely positioned to drive cross-border synergies and deliver the performance expected by the institutional investment landscape in Asia.

Hashtag: #CardumenCapital #Illumex #NVIDIA #DeepTech #AI #VentureCapital #M&A #Taiwan


The issuer is solely responsible for the content of this announcement.

About Cardumen Capital

Cardumen Capital, a leading global venture capital firm supervised by the CNMV (Spanish Securities Market Commission), was founded in 2018 by Gonzalo Martínez de Azagra and Igor de la Sota. With over 15 years of investment experience and a presence across Europe, the Middle East, and Asia, the firm specializes in investing in private market companies and funds, supporting innovation, disruptive technologies, and long-term value creation.

Backed by leading institutional investors, corporations, and family offices, Cardumen Capital focuses on generating sustainable long-term returns through its specialized DeepTech investment strategies and a demonstrated track record of connecting strategic capital with the global innovation frontier.

Gartner® Recognizes OpenWay Group in the 2026 Market Guide for Digital Commerce Payment Platforms

MONT-SAINT-GUILBERT, Belgium, March 4, 2026 /PRNewswire/ — OpenWay is included in the 2026 Gartner Market Guide for Digital Commerce Payment Platforms.

Gartner® Recognizes OpenWay Group in the 2026 Market Guide for Digital Payment Platforms
Gartner® Recognizes OpenWay Group in the 2026 Market Guide for Digital Payment Platforms

As noted by Gartner, “Digital commerce leaders responsible for online and mobile payments should use this Market Guide to understand this complex, rapidly evolving market, as well as the related vendor platform landscape.”

In the report, Gartner identified OpenWay as a Representative Vendor for its product, the Way4 Merchant Acquiring platform.

The report states that the digital commerce payment market remains complex and dynamic. While certain segments such as wholesale processing, hosted payment pages, and tokenization have reached maturity, the market continues to evolve. Gartner notes that the global retail e-commerce market is projected to grow at a compound annual growth rate of 6.3 % from 2025 to 2030, reaching a market size of $4,964 trillion dollars by 2030 up from $3,660 trillion in 2025. In this context, Gartner recommends that organizations treat payments as a strategic business function and select vendors that provide opportunities to increase revenue and profit through value-added services that allow them to manage the payment experience and optimize acceptance rates. They should ensure that the business’ current and future payment strategy can be supported by the selected vendor by validating market support, payment methods and services the business requires. Moreover, geographic expansion plans that impact payments for the next three to five years are recommended to be included in that strategy.

Way4 is a platform that supports diverse payment scenarios across digital commerce ecosystems.

Way4 Merchant Acquiring is a full-stack digital payment software platform used by leading global banks, top-tier acquirers, payment processors, PayFacs, PSPs, retailers, and fintechs. It supports all merchant categories and sizes, multiple business models, and both card and non-card payments, including digital currencies, wallets, and quasi-money instruments such as fuel liters, airtime, or sustainability points. Built as a configurable omnichannel real-time platform, Way4 enables large acquirers to launch new payment solutions within months and introduce new products or pricing models within weeks while maintaining high availability for large-scale cross-border portfolios of up to 2 million merchants.

We believe OpenWay’s inclusion reflects Gartner’s identification of vendors that meet these criteria within the Market Guide’s defined scope.

Gartner Disclaimer
Gartner, Market Guide for Digital Commerce Payment Platforms, Debbie Buckland, Peter Ryan, 12 January 2026

GARTNER is a trademark of Gartner, Inc. and/or its affiliates. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

VinEnergo Announces Global Strategy, Deploys First 10 GW International Renewable Energy Portfolio


HANOI, VIETNAM – Media OutReach Newswire – 4 March 2026 – VinEnergo announces its large-scale global expansion plan, initially focusing on Asia and Europe with a renewable energy project portfolio totaling 10 GW that has officially secured development agreements. In addition to the capacity already approved in Vietnam, over the next three years VinEnergo will continue expanding its operations and increase its total deployed capacity to 100 GW, positioning itself as a leading global renewable energy enterprise and deepening its participation in the international energy transition.

Mr. Nguyen Anh Khoa, CEO of VinEnergo (left), and Mr. Karsten Nielsen, Founder and CEO of GreenGo Energy Group (right), at the partnership signing ceremony between the two parties.
Mr. Nguyen Anh Khoa, CEO of VinEnergo (left), and Mr. Karsten Nielsen, Founder and CEO of GreenGo Energy Group (right), at the partnership signing ceremony between the two parties.

Under its overall plan, VinEnergo targets the development of 100 GW of renewable energy over the next three years, including 50 GW in core international markets such as North America, Northern Europe, the Mediterranean, and Southeast Asia. These regions demonstrate rapidly-growing power demand, strong renewable energy promotion policies, and significant development headroom for international investors.

In parallel, VinEnergo will also explore expansion into other potential markets such as Central Asia and Africa, where electricity demand and emissions reduction requirements are rising rapidly. Through collaboration with governments and relevant stakeholders, VinEnergo will develop sustainable energy sources, support businesses in accessing clean electricity, contribute to Net Zero goals, and directly participate in shaping green energy policy.

To establish a solid foundation for the structured and long-term deployment of renewable energy projects, VinEnergo has signed partnerships with international financial institutions to access green credit. In addition, VinEnergo has reached agreements with multiple reputable foreign partners to develop a 10 GW project portfolio, with the overall objective of mastering all stages, from design, schedule management, and commercial structuring to long-term operations.

Specifically, in Northern Europe, VinEnergo partners with GreenGo Energy to develop a renewable energy project portfolio of 2 GW in Denmark and Sweden. In the long term, the company plans to expand its capacity in Northern Europe and across Europe to 6.2 GW.

In the Philippines, VinEnergo will develop projects totaling 1.3 GW with NKS Renewables Inc, 1.2 GW with URG Asia Corporation, and 1.3 GW with 11.11 Growth Properties, focusing on large-scale solar power projects in favorable areas such as Luzon, Visayas, and Mindanao.

In these co-development projects, VinEnergo holds over 80 percent ownership and acts as the primary developer, responsible for capital mobilization, construction, and long-term operations. Several projects commenced in early 2026 and are expected to begin operations during 2027 to 2028.

Mr. Andre Pablo G. Fausto, President of NKS Renewables (left), and Mr. Nguyen Anh Khoa, CEO of VinEnergo (right), at the partnership signing ceremony between the two parties.
Mr. Andre Pablo G. Fausto, President of NKS Renewables (left), and Mr. Nguyen Anh Khoa, CEO of VinEnergo (right), at the partnership signing ceremony between the two parties.

With in-house capability in the manufacturing and integration of battery energy storage systems (BESS), VinEnergo can standardize design, secure equipment supply proactively, and synchronize technical solutions across its entire portfolio. This ensures high operational stability, reduces schedule risk, and optimizes project economics, particularly in markets with high renewable penetration and increasingly stringent dispatch requirements.

According to the plan, in the first quarter of 2026, VinEnergo will increase its total international renewable energy portfolio to 20 GW, with at least 8 GW of additional projects in Southeast Asia and Africa to be signed during the period.

Mr. Nguyen Anh Khoa, Chief Executive Officer of VinEnergo, stated: “Entering 2026, VinEnergo moves into a new development phase with the aspiration to become a renewable energy enterprise with global scale and competitiveness. The simultaneous deployment of a large portfolio across multiple markets affirms our capacity for governance and execution of complex projects. VinEnergo believes we will make an important contribution to the global energy transition process, while elevating the stature of Vietnamese enterprises on the global green energy map.”

In 2025, VinEnergo broke ground on the Hai Phong LNG thermal power plant, with a total investment of approximately VND 178 trillion and a designed capacity of 4,800 MW, placing it among the largest LNG-to-power projects in Vietnam and globally. VinEnergo has also been assigned as the investor for two offshore wind power projects in Ha Tinh, totaling approximately 900 MW with a combined investment exceeding VND 39 trillion.

Most recently, VinEnergo also invested in Phase 1 of the Hon Trau Wind Power Plant project in Gia Lai, with a capacity of 750 MW, one of the largest renewable energy projects in the province. In addition, VinEnergo has been approved as the qualified investor for the Vinh Thuan Wind Power Project, with a capacity of 143 MW.

Co-operation agreements both domestically and internationally reflect partners’ confidence in VinEnergo’s financial strength, governance, and execution capability, while affirming the company’s increasingly established position in the international renewable energy value chain.

With a long-term development orientation and as part of the Vingroup ecosystem, VinEnergo pursues the mission of providing clean, stable, and efficient energy, aligned with disciplined investment, international governance standards, and sustainable value creation for the community, while proactively adopting the latest trends such as AI and big data applications in operations and smart power solution development.

Hashtag: #VinEnergo

The issuer is solely responsible for the content of this announcement.

About VinEnergo

As part of the Green Energy pillar of Vingroup, VinEnergo Energy Joint Stock Company envisions becoming a comprehensive green energy investor and developer, contributing to Vietnam’s net-zero emissions goal and strengthening the country’s position on the global energy map. VinEnergo focuses on developing large-scale solar and wind power projects, applying modern technologies and international standards in safety and quality.

Find out more at:

About GreenGo Energy

GreenGo Energy was founded in 2011 with the vision to accelerate the global shift to renewable energy. GreenGo Energy’s 360-degree full-services platform includes project origination, investment structuring, development, offtake, EPC management and asset management services.

GreenGo Energy has 40 GW of solar, wind, BESS, and Megaton PtX projects in various stages of development and construction in Europe, USA and Africa/MENA. GreenGo Energy is headquartered in Denmark.

About NKS Renewables Inc
NKS Renewables Inc., or NKSRI, is a subsidiary of NKS Corporation Group and focuses mainly on developing utility-size solar power projects, mostly with international investors, and is currently engaged with other Asian and European investors. Its President, being renowned as the pioneer of the first large-scale floating solar project in the Philippines, has been in the power industry for more than 35 years.

About URG Asia Corporation
URG Asia Corporation is the Philippine renewable energy development arm of URG Australasia, a diversified industrial group with proven execution across logistics, commodities, construction materials, and infrastructure. Leveraging its land consolidation advantage, URG is progressing up to ~800 MWp of utility‑scale solar projects (~550 ha) toward RTB by 2027, with over 1.2 GWp of additional long‑term capacity available across its land bank.

About 11.11 Growth Properties
11.11 Growth is a real estate platform in the Philippines that is currently expanding into the development of utility scale renewable energy projects. The company focuses on developing solar power projects in Luzon, Visayas, and Mindanao, supported by a land bank totaling more than 1,700 hectares. It has a well-structured and multidisciplinary team covering project development, technical services, land aggregation and acquisition, and regulatory compliance, enabling full-cycle project execution from start to finish. The platform is led by Alberto “Bert” Dalusung III, a seasoned renewable energy professional with extensive expertise and a broad industry network across the Philippines.

Vinhomes Green Paradise Gains Traction as a Multigenerational Global Investment


HANOI, VIETNAM – Media OutReach Newswire – 4 March 2026 – Can Gio is Ho Chi Minh City’s coastal district, a threshold where a metropolis of more than 10 million people meets the vast ecological reserve of mangrove forests and the open sea. Such geography cannot be replicated. Now, at this rare intersection of city and biosphere, Vinhomes Green Paradise is steadily transforming vision into reality, shaping a new coastal urban paradigm for the next generation.

Photo (27).jpg

Among hundreds of candidates from across the globe, Vinhomes Green Paradise has emerged as the first official participant in the global campaign New7Wonders’ “7 Wonders of Future Cities”. It signals that on the southern edge of Ho Chi Minh City, in Can Gio’s coastal expanse, a new urban thesis is being tested – one in which development is calibrated not by vertical ambition alone, but by the durability of its quality of life.

“Vinhomes Green Paradise is a truly compelling model for the concept of a ‘future city,'” said Jean-Paul de la Fuente, Director of New7Wonders and President of the “7 Wonders of Future Cities” campaign. “Here, the benchmark of progress is measured in the quality of living across generations.”

That future is now materializing at pace. Construction advances with uncommon velocity. Infrastructure grids are being laid with the discipline of long-term urban choreography. At the center of this unfolding ecosystem lies a 50-meter-wide artery known as the “Future Boulevard” – planned as the district’s commercial spine and among the earliest components to be completed and activated.

To acquire a Boulevard Prime townhouse along this axis is, by many measures, to participate in the district’s economic overture before the crescendo. Can Gio is envisioned as a tourism capital welcoming up to 40 million visitors annually. As infrastructure scales and connectivity deepens, the pricing paradigm is expected to reset accordingly. Early ownership, therefore, is a position in an emerging consumption corridor.

The Irreplicable Value of a “Rare Axis”

In urban economics, frontage along a primary commercial axis carries a structural premium. In Can Gio, this logic is rendered tangible along the 50-meter Future Boulevard, the first commercial lifeline of Vinhomes Green Paradise.

Each segment of the street is anchored to a destination of international scale: a six-star luxury resort; the 5,000-seat Blue Waves Theater; the global entertainment complex VinWonders; a Safari park; the 24/7 retail and leisure hub Cosmo Bay; Landmark Harbour international marina; twin 18-hole golf courses; and a five-star Vinmec International Hospital.

According to development plans, these flagship amenities are slated for substantial completion by the third quarter of 2027. Once synchronized in operation, the boulevard will transcend its infrastructural role. It will function as a sustained “consumption corridor” – channeling a stable, continuous stream of visitors past the doors of Boulevard Prime properties.

The anticipated clientele arrives for resort stays, theatrical performances, golf tournaments, wellness programs, global events – activities that imply longer dwell times and elevated discretionary spending. The rhythm of commerce here is not circumscribed by office hours. It extends day and night, across all seasons.

Such an environment is naturally suited to structured, premium service models: fine-dining establishments; curated boutiques; concept stores; flagship showrooms; spa and wellness centers; branded hospitality hybrids. The boulevard’s design, retail interlaced with major attractions, ensures that each property benefits not from a single demand stream, but from layered and overlapping consumer flows.

This “amenity-adjacent” architecture confers resilience. When consumption is underwritten by an entire ecosystem rather than a solitary anchor, volatility is diffused. As the district matures and visitor patterns stabilize, assets positioned along the core axis are likely to see their competitive advantages sharpen.

It is this structural clarity, of connectivity, scarcity and projected demand, that positions Boulevard Prime as a focal point for international capital seeking long-horizon growth in Southeast Asia’s evolving urban markets.

Securing Capital Costs, Anticipating the Cycle

Urban planners often note that the intrinsic value of commercial property along a central axis derives from infrastructural singularity. A city may expand outward, layering additional amenities and residential clusters, but it rarely replicates its primary connective spine. Once established, such axes become enduring frameworks around which value consolidates.

In Can Gio, the 50-meter Future Boulevard is the sole route designed to link, directly and comprehensively, the district’s full spectrum of large-scale amenities. The supply of Boulevard Prime townhouses along this stretch is, by definition, finite. As the urban organism reaches operational maturity, that scarcity is expected to become increasingly pronounced.

If rarity underwrites long-term value, timing determines margin. At the present juncture, while the boulevard is advancing toward completion, pricing does not yet fully encode the district’s projected consumption capacity. Early investors retain latitude in site selection and stand to capture the repricing that typically accompanies infrastructural activation.

Complementing locational advantage is a financing structure engineered to minimize capital risk. The program “Buy a Vinhomes Home – No Worries About Interest Rates” offers 0% interest support for 36 months, followed by a capped maximum rate of 9% per annum for the subsequent 24 months. In effect, investors can model capital costs across a five-year horizon with unusual clarity.

This structure is calibrated to an entire economic cycle. Rather than remaining exposed to market rate volatility, investors can establish predictable cash-flow projections from the outset. In a climate where interest rates exhibit upward pressure and liquidity discipline tempers expansion plans, such insulation functions as a financial shield.

Long-term fixed-rate commitments of this duration are not commonplace in the current market. They presuppose balance-sheet strength and a willingness on the part of the developer to absorb rate risk alongside buyers. For investors, particularly those navigating cross-border allocations, this arrangement reduces friction at the point of entry and fortifies holding strategy during the formative years of the district’s growth.

A City Measured in Generations

What distinguishes Vinhomes Green Paradise is not a singular building or amenity, but its integrative thesis. It proposes that tourism, culture, healthcare, recreation and commerce need not exist as disjointed clusters. When orchestrated deliberately, they can reinforce one another, creating both a lifestyle destination and a durable economic engine.

In that sense, the project’s participation in the New7Wonders campaign reads less as accolade and more as validation of intent. The aspiration is to cultivate a city where daily life, for residents, entrepreneurs and visitors alike, unfolds within a coherent, future-oriented framework.

If cities of the past were defined by fortifications or factories, and the cities of the 20th century by skylines, the cities of the future may well be judged by their capacity to harmonize infrastructure with human experience. In Can Gio, that experiment is already underway – not as speculation, but as construction steel rising against the coastal horizon.

Hashtag: #Vinhomes

The issuer is solely responsible for the content of this announcement.